Dr. Mark Bennet Kahn, MD Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 8200 Flourtown Ave, Ste 2, Wyndmoor, PA 19038 Phone: 215-836-5120 Fax: 215-248-8989 |
John Meilahn, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 8814 Patton Rd, Wyndmoor, PA 19038 Phone: 215-680-7609 |
News Archive
The swine flu (H1N1) pandemic has received extensive media coverage this year. The World Health Organization, in addition to providing frequent updates about cases of infection and death tolls, recommends hyper vigilance in daily hygiene such as frequent hand washing or sneezing into the crook of our arms. News reports at all levels, from local school closures to airport screenings and global disease surveillance, continue to remind us of the high risk.
"State leaders, trying to dig out of a hole in the current two-year budget before the next one has to be whacked, ordered agencies Tuesday to further curb spending. Agency chiefs were told in a letter that they must reduce expenditures by 2.5% in the remaining nine months of the fiscal year. Managers of the state Medicaid program immediately announced they would cut another 1% from the fees paid to doctors, dentists and hospitals, along with 2% in payments to nursing homes and home health care providers. The decreases take effect Feb. 1, and they come on top of 1% cuts that kicked in just before Labor Day" (Garrett, 12/8).
The Associated Press/The Houston Chronicle reports that Texas lawmakers will add $5 million to expand mental health services — specifically veteran-to-veteran peer support groups — in the state. "Gov. Rick Perry on Monday announced the plan that calls for directing money from the state Health and Human Services Commission budget toward mental health treatment programs for veterans and their families" (11/9).
Gilead Sciences, Inc. and CGI Pharmaceuticals, Inc., a privately-held, development-stage pharmaceutical company focused on small molecule chemistry and kinase biology, today announced the signing of a definitive agreement pursuant to which Gilead will acquire CGI. Under the terms of the agreement, Gilead will acquire CGI for up to $120 million, the majority as an upfront payment and the remaining based on clinical development progress, all of which will be financed through available cash on hand.
Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceuticals and parenteral drug products, announced today that it has completed the installation of a new INOVA H3-5 high-speed syringe filling line.
› Verified 5 days ago